RTW INVESTMENTS, LP
Q1 2022 13F-HR Holdings
Net value change ($000)
-2,016,684
(-29.4%)
New positions
2
Sold out positions
20
Turnover %
17.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CUTERA INC | 47,585 | 82.4% |
| CCCC | 29,608 | 36.9% |
| PTGX | 24,620 | 27.7% |
| CinCor Pharma, Inc. | 24,375 | NEW |
| 2seventy bio, Inc. | 20,975 | NEW |
| RLMD | 19,299 | 39.2% |
| FULC | 17,000 | 24.9% |
| IMUX | 14,155 | 86.2% |
| IMCR | 12,951 | 30.4% |
| PMVP | 11,758 | 17.1% |
Top Reduces (Value $000, Stocks/ETFs)
| SPY | -422,590 | -100.0% |
| IVERIC bio, Inc. | -112,402 | -100.0% |
| Mirati Therapeutics, Inc. | -100,670 | -43.9% |
| NTRA | -95,919 | -55.2% |
| RCKT | -94,343 | -27.3% |
| iTeos Therapeutics, Inc. | -93,820 | -85.6% |
| APLS | -91,505 | -97.2% |
| MASI | -84,745 | -34.1% |
| TMO | -70,271 | -24.2% |
| ALNY | -60,194 | -18.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|